Walpar Nutritions Ltd.

View in App
82.25 +3.90 ▲5.0%

26 May 2023, 03:31:51 PM
Volume: 6,000

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website
Market Cap 38.62 Cr.
Enterprise Value(EV) 41.82 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 1.26 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 65.45 Trailing Twelve Months Ending 2023-03
Industry PE 31.87 Trailing Twelve Months Ending 2023-03
Book Value / Share 25.28 Trailing Twelve Months Ending 2023-03
Price to Book Value 3.25 Calculated using Price: 82.25
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.47 Cr. 4,695,220 Shares
FaceValue 10
About Walpar Nutritions Ltd.
The company does third party manufacturing of Nutraceutical products on job work basis. The raw material is procured by it for which it receives order for manufacturing their semi-finished/finished Nutraceutical products. It also does marketing of products which are manufactured by it under its own brand. Its products are sold through whole seller distributors/ sales distribution channels. It is also engage in trading of raw material used in manufacturing Nutraceutical products. Such raw material is basically also raw material which is used in manufacturing of its own products.

Walpar Nutritions Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Walpar Nutritions Ltd. Performance

View details >>
1 Day
+4.98%
1 Week
+4.44%
1 Month
+17.50%
3 Month
+45.32%
6 Month
+47.80%
1 Year
+107.96%
2 Year
5 Year
10 Year

Walpar Nutritions Ltd. Fundamental Ratios

View details >>
2 years 2021-03 2022-03
Return on Equity (%) 3.28 4.58
Return on Capital Employed (%) 2.83 5.00
Return on Assets (%) 0.83 1.55

Walpar Nutritions Ltd. Balance Sheet

View details >>
Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 5 11 12
Non Curr. Liab. 5 1 6
Curr. Liab. 9 14 15
Minority Int. 0 2 2
Equity & Liab. 18 28 34
Non Curr. Assets 3 9 11
Curr. Assets 15 19 24
Misc. Exp. not W/O 0 0
Total Assets 18 28 34

Walpar Nutritions Ltd. Profit and Loss

View details >>
Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 6 27
Other Income 0
Total Income 6 27
Total Expenditure -6 -26
PBIDT 0 1
Interest 0 0
Depreciation 0 0
Taxation 0 0
Exceptional Items 0
PAT 0 0
Minority Interest 0
Share Associate
Other Related Items
Consolidated Net Profit 0 0
Adjusted EPS 0 1

Walpar Nutritions Ltd. Cash Flow

View details >>
Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 -1
Cash Fr. Inv. -2 -6
Cash Fr. Finan. 3 7
Net Change 1 -1
Cash & Cash Eqvt 1 0

Walpar Nutritions Ltd. Shareholding Pattern

View details >>
4 Qtrs 2021-09 (%) 2022-03 (%) 2022-09 (%) 2023-03 (%)
Promoter 71.02 71.02 70.58 70.54
Public 28.98 28.98 29.42 29.46
Depository Receipts 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00

Walpar Nutritions Ltd. Announcements

View details >>

No Corporate Announcement found.

Walpar Nutritions Ltd. Technical Scans

View details >>
Fri, 26 May 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Week High Close Crossing Last Week High
Opening at High Opening at High
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High

Walpar Nutritions Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 232,891.45 969.90 +2.6%
Divi's Laboratories Ltd. 93,212.66 3,514.00 +2.3%
Cipla Ltd. 76,767.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. 75,437.96 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. 66,286.16 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. 57,611.88 1,700.25 -0.1%
Mankind Pharma Ltd. 53,007.87 1,323.60 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.48 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 51.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 27.40 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.74 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 86.68 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 69.29 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 39.70 1,323.60 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.16 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 3.28 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.24 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.75 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 9.03 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.10 1,323.60 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 0.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,323.60 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,323.60 -0.3%

Walpar Nutritions Ltd. FAQ's

What is Walpar Nutritions share price?
Can I buy Walpar Nutritions shares now?
What is the Market Cap of Walpar Nutritions?
What are the key metrics to analyse Walpar Nutritions?
What is the 52 Week High and Low of Walpar Nutritions?
What is the trend of Walpar Nutritions share price?